Status:
UNKNOWN
Vulvar Cancer Individualized Scoring System (VCISS)
Lead Sponsor:
Assiut University
Conditions:
Vulvar Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
This study aims to develop a machine learning-based prediction model for patients with vulvar cancer. This model will utilize patient characteristics and disease features to determine the disease's pr...
Detailed Description
Vulvar cancer (VC) is a relatively rare gynecological cancer accounting for 5-8% of all cases \[1\]. It comes the fourth among the commonest gynecological cancers and tends to affect women after meno...
Eligibility Criteria
Inclusion
- Women diagnosed with Vulvar cancer and treated at collaborating centers between January 1st, 2008, and December 31st, 2017
- women aged 18 years old or older, complete follow-up on for at least 3 years, unless censored by mortality.
Exclusion
- Women will be excluded from the study if there were lost to follow-up before 3 years post-treatment
- If the patient did not receive their treatment in the receptive centers
- If the patient were diagnosed with synchronous cancers
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06007625
Start Date
January 1 2024
End Date
December 1 2024
Last Update
August 23 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria University Main Hospital
Alexandria, Egypt, 21516
2
Assiut Hospitals university
Asyut, Egypt, 71511